← Back to directory

Reinhard Hohlfeld

Researcher Next ID · RN-029745

Researcher · Medicine

Munich Cluster for Systems Neurology

Munich, Slovakia

Not currently recruitingFunding unknown
Works count
551
Citation count
35,519
H-index
99
i10-index
280

Research interests

Medicine
Immunology and Microbiology
Multiple Sclerosis Research Studies
Peripheral Neuropathies and Disorders
Immunotherapy and Immune Responses
T-cell and B-cell Immunology
Myasthenia Gravis and Thymoma

Publications

  • Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    Cell · 2022 · 10.1016/j.cell.2022.08.021

  • Role of B Cells in Multiple Sclerosis and Related Disorders

    Annals of Neurology · 2020 · 10.1002/ana.25927

  • Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    The Lancet Neurology · 2018 · 10.1016/s1474-4422(18)30069-3

  • Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

    Proceedings of the National Academy of Sciences · 2017 · https://doi.org/10.1073/pnas.1711233114

  • Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

    Journal of Neurology · 2016 · 10.1007/s00415-016-8045-z

  • γ-secretase directly sheds the survival receptor BCMA from plasma cells

    Nature Communications · 2015 · 10.1038/ncomms8333

  • Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

    Neurology · 2011 · 10.1212/wnl.0b013e318228c0b1

  • Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

    Neurology · 2011 · 10.1212/wnl.0b013e3182152881

  • A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

    New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0909494

  • MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

    Brain · 2009 · https://doi.org/10.1093/brain/awp300

  • Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

    Nature Clinical Practice Neurology · 2008 · 10.1038/ncpneuro0764

  • Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis

    Nature Medicine · 2008 · 10.1038/nm1714

  • Neurofascin as a novel target for autoantibody-mediated axonal injury

    The Journal of Experimental Medicine · 2007 · 10.1084/jem.20071053

  • B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation

    Annals of Neurology · 2006 · 10.1002/ana.20890

  • BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

    The Journal of Experimental Medicine · 2005 · https://doi.org/10.1084/jem.20041674

  • Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment

    Brain · 2005 · 10.1093/brain/awh680

  • Multiple sclerosis: Brain-infiltrating CD8 + T cells persist as clonal expansions in the cerebrospinal fluid and blood

    Proceedings of the National Academy of Sciences · 2004 · 10.1073/pnas.0308689100

  • Polymyositis and dermatomyositis

    The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)14368-1

  • BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

    Brain · 2002 · 10.1093/brain/awf015

  • Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction

    The Journal of Experimental Medicine · 2000 · 10.1084/jem.192.3.393

  • Multiple sclerosis: Comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

    Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.97.13.7452

  • Multiple sclerosis

    Neurology · 1999 · 10.1212/wnl.53.8.1622

  • Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

    The Journal of Experimental Medicine · 1999 · 10.1084/jem.189.5.865

  • Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

    Brain · 1997 · 10.1093/brain/120.5.865

  • Polymyositis and Dermatomyositis

    Neurocritical Care · 1994 · 10.1007/978-3-642-87602-8_72

Current projects

    No projects listed.